NewCa.com: The JAMP Pharma Group Launches Prjamp Apremilast, A New
• The JAMP Pharma Group launches Apremilast, a specialty generic, offering a more affordable alternative to the reference product Otezla® (marketed by Amgen
Louis Pilon Pharma Group Amgen Canada Inc Dermatrials Research Incorporated Ontario Dermatologist Dermatrials Research
Source: newca.com